Blauvelt, A., Fowler, Jr., J. F., Schuck, E., Jauch, J., Woehling, H. and Leonardi, C. L. (2017) “A Randomized, Double-Blind, Multicenter Study to Compare the Efficacy, Safety, and Immunogenicity of a Proposed Adalimumab Biosimilar (GP2017) with Originator Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis”, SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s29. doi: 10.25251/skin.1.supp.28.